A sweeping shift in federal policy—capped, at least temporarily, by a federal judge’s decision to halt the NIH’s proposed 15% ...
The total funding amount awarded to Moffitt last year, $44.7 million, was once again the highest in Florida and nearly double ...
A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in approving crucial clinical trials.
GEORGE F. LEE / GLEE @STARADVERTISER.COM The University of Hawaii Cancer Center in Kakaako as seen Thursday. GEORGE F. LEE / ...
Oncologist Dr. Sarah Cate told Newsweek: "Many women simply don't make time for themselves, since they are working and often ...
There is reason for recipients of federal dollars to be searching urgently for alternative sources of revenue. Multiple ...
Researchers from TMC and NIBMG have uncovered key genomic factors contributing to hormone treatment resistance in breast cancer. The study identifies mutations in three genes, DNA repair deficiencies, ...
The Trump administration has sent an earthquake through the medical research community. The National Institutes of Health is ...
Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...
What's at stake in cancer research as the Trump administration moves to cut "indirect funding" to universities? The immediate past leader of the National Cancer Institute says clinical trials will be ...
Learn how false claims and exaggerated treatment information can harm cancer patients and their support network.
A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results